Challenge: A U.S. multinational had 14 manufacturing sites in Europe, the Middle East and Africa (EMEA). Each site booked transportation using a carrier-specific terminal and website, which resulted in a multitude of site-specific and carrier-specific shipping systems. Consequently, the company lacked centralized visibility for shipment movements and transportation spend.
The coronavirus pandemic has laid bare the inadequacies of many supply chains when it comes to ensuring the safe, secure and rapid delivery of drugs and other critical supplies in a health crisis.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.